Clinical trial
Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse…
NCT00294775 · Odense University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00294775 |
|---|---|
| Title | Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis |
| Official title | Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis - Effect of Blockade of the Angiotensin-II Receptor |
| Lead sponsor | Odense University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Aortic Valve Stenosis, Left Ventricular Hypertrophy, Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Candesartan |
| Enrollment | 140 |
| Start date | Feb 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Feb 22, 2006 |
| Last update posted | Jun 30, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: